Allen WL - Search Results

1

Calbindin 2 (CALB2) regulates 5-fluorouracil sensitivity in colorectal cancer by modulating the intrinsic apoptotic pathway.

Stevenson L, Allen WL, Proutski I, Stewart G, Johnston L, McCloskey K, Wilson PM, Longley DB, Johnston PG. Stevenson L, et al. Among authors: allen wl. PLoS One. 2011;6(5):e20276. doi: 10.1371/journal.pone.0020276. Epub 2011 May 24. PLoS One. 2011. PMID: 21629658 Free PMC article.

2

Combined inhibition of FLIP and XIAP induces Bax-independent apoptosis in type II colorectal cancer cells.

Wilson TR, McEwan M, McLaughlin K, Le Clorennec C, Allen WL, Fennell DA, Johnston PG, Longley DB. Wilson TR, et al. Among authors: allen wl. Oncogene. 2009 Jan 8;28(1):63-72. doi: 10.1038/onc.2008.366. Epub 2008 Sep 29. Oncogene. 2009. PMID: 18820704

3

Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer.

Turkington RC, Longley DB, Allen WL, Stevenson L, McLaughlin K, Dunne PD, Blayney JK, Salto-Tellez M, Van Schaeybroeck S, Johnston PG. Turkington RC, et al. Among authors: allen wl. Cell Death Dis. 2014 Feb 6;5(2):e1046. doi: 10.1038/cddis.2014.10. Cell Death Dis. 2014. PMID: 24503538 Free PMC article.

4

Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer.

McDermott U, Longley DB, Galligan L, Allen W, Wilson T, Johnston PG. McDermott U, et al. Cancer Res. 2005 Oct 1;65(19):8951-60. doi: 10.1158/0008-5472.CAN-05-0961. Cancer Res. 2005. PMID: 16204068

5

Role of genomic markers in colorectal cancer treatment.

Allen WL, Johnston PG. Allen WL, et al. J Clin Oncol. 2005 Jul 10;23(20):4545-52. doi: 10.1200/JCO.2005.19.752. J Clin Oncol. 2005. PMID: 16002846 Review.

6

Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer.

Boyer J, Allen WL, McLean EG, Wilson PM, McCulla A, Moore S, Longley DB, Caldas C, Johnston PG. Boyer J, et al. Among authors: allen wl. Cancer Res. 2006 Mar 1;66(5):2765-77. doi: 10.1158/0008-5472.CAN-05-2693. Cancer Res. 2006. PMID: 16510598

7

Drug resistance, predictive markers and pharmacogenomics in colorectal cancer.

Longley DB, Allen WL, Johnston PG. Longley DB, et al. Among authors: allen wl. Biochim Biophys Acta. 2006 Dec;1766(2):184-96. doi: 10.1016/j.bbcan.2006.08.001. Epub 2006 Aug 9. Biochim Biophys Acta. 2006. PMID: 16973289 Review.

8

The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells.

Allen WL, McLean EG, Boyer J, McCulla A, Wilson PM, Coyle V, Longley DB, Casero RA Jr, Johnston PG. Allen WL, et al. Mol Cancer Ther. 2007 Jan;6(1):128-37. doi: 10.1158/1535-7163.MCT-06-0303. Mol Cancer Ther. 2007. PMID: 17237273

9

Clinical determinants of response to irinotecan-based therapy derived from cell line models.

Allen WL, Coyle VM, Jithesh PV, Proutski I, Stevenson L, Fenning C, Longley DB, Wilson RH, Gordon M, Lenz HJ, Johnston PG. Allen WL, et al. Clin Cancer Res. 2008 Oct 15;14(20):6647-55. doi: 10.1158/1078-0432.CCR-08-0452. Clin Cancer Res. 2008. PMID: 18927307

10

Prostate-derived factor--a novel inhibitor of drug-induced cell death in colon cancer cells.

Proutski I, Stevenson L, Allen WL, McCulla A, Boyer J, McLean EG, Longley DB, Johnston PG. Proutski I, et al. Among authors: allen wl. Mol Cancer Ther. 2009 Sep;8(9):2566-74. doi: 10.1158/1535-7163.MCT-09-0158. Epub 2009 Sep 1. Mol Cancer Ther. 2009. PMID: 19723892

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters